drugset / Trial / NCT00166686

Clonidine for Neurocognitive Sequelae

NCT00166686 ↗

RandomizedCrossoverDouble-blindTreatment

Summary

The goals of the study are to determine the efficacy of clonidine in the treatment of children with neurocognitive sequelae following the therapy of long term malignancies. In addition, the study hopes to determine the long-term effect of clonidine on children's academic and psychosocial function.

Timeline

Start
—
Primary completion
—
Completion
—

Outcome

Outcome not reported

Stopped: “Study was never initiated”

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonidine Other / unclassified — —